Compare Cigna Corp (CI) vs Skyworks Solutions Inc (SWKS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Skyworks Solutions Inc — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Skyworks Solutions Inc trades at $68.28 (market cap $10.35B). The key difference: Cigna Corp is far larger — about 7.1× Skyworks Solutions Inc's market cap, and Skyworks Solutions Inc pays the higher dividend (4.13%). Which is the better fit depends on your goals.
| CI | SWKS | |
|---|---|---|
Market Cap | $73.56B | $10.35B |
Sector | Health | Technology |
52-Week High | $311.00 | $83.40 |
52-Week Low | $244.41 | $52.50 |
Enterprise Value | $98.27B | $10.23B |
Dividend Yield | 2.24% | 4.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Skyworks Solutions (SWKS) trades at $70.62, up 5.66% today, showing strong momentum despite mixed technical signals. The company delivered three consecutive quarterly earnings beats, with Q3 2026 EPS of $1.08 exceeding expectations. Revenue trends show contraction from $5.5B in 2022 to $4.1B in 2025, while profit margins have compressed from 23.24% to 11.67% over the same period. The pending Qorvo combination represents a significant strategic development that could reshape the company's competitive positioning in the semiconductor sector.
The stock presents a complex investment case with strong analyst support (58% buy ratings) but faces revenue headwinds and margin pressure. The $66 consensus price target suggests limited upside from current levels, while the ongoing merger process introduces integration execution risks. Investors must weigh the potential benefits of diversification against the challenges of declining profitability in the core business.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →
